Andrea B. Apolo, MD, discusses a pooled analysis of 2 cohorts of the phase 1b JAVELIN trial, which is exploring avelumab (Bavencio) for the treatment of patients with metastatic urothelial carcinoma.
Clinical Trials and New Techniques Advance the Bladder Cancer Treatment Landscape
May 31st 2023For Bladder Cancer Awareness Month, Jahan Aghalar, MD, discussed the latest advancements in treating patients with bladder cancer along with which targets have helped to push the field forward.
Read More
Guidance on Treating GIST in the Second-Line and Beyond
May 30th 2023In an interview with Targeted Oncology, Alexander Helfand, MD, discussed the treatment of GIST in the second-line setting, as well as later lines, including the available options, guideline recommendations, and ongoing research.
Read More
2 Clarke Drive
Cranbury, NJ 08512